The EU marketing environment: Pharmaceuticals and Japanese strategy

Sally Dibb, Yvonne Russell, Lyndon Simkin

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

The marketing environment those external forces that directly or indirectly influence an organisation's trading, acquisitions of inputs and generation of outputs, but over which the organisation has little or no control - is in marketing strategy acknowledged to be an important determinant of strategy selection. Recent changes within the European Union have illustrated the workings of these forces. In the emotive, highly competitive, multi-million dollar pharmaceuticals industry, the effect of the elements of the marketing environment are extensive, particularly for a Japanese player attempting to break into the European 'Single Market'. This article by Sally Dibb, Yvonne Russell and Lyndon Simkin describes the implications in pharmaceuticals of the broader, external trading environment and the marketing environment, using Japan's Sankyo as an illustrative case.

Original languageEnglish
Pages (from-to)195-205
Number of pages11
JournalEuropean Management Journal
Volume15
Issue number2
DOIs
Publication statusPublished - Apr 1997
Externally publishedYes

Fingerprint

Pharmaceuticals
Marketing environment
Single European market
Japan
Marketing strategy
European Union
Pharmaceutical industry

ASJC Scopus subject areas

  • Strategy and Management

Cite this

The EU marketing environment : Pharmaceuticals and Japanese strategy. / Dibb, Sally; Russell, Yvonne; Simkin, Lyndon.

In: European Management Journal, Vol. 15, No. 2, 04.1997, p. 195-205.

Research output: Contribution to journalArticle

@article{a3b94c42fbf6455790aad278633f0f98,
title = "The EU marketing environment: Pharmaceuticals and Japanese strategy",
abstract = "The marketing environment those external forces that directly or indirectly influence an organisation's trading, acquisitions of inputs and generation of outputs, but over which the organisation has little or no control - is in marketing strategy acknowledged to be an important determinant of strategy selection. Recent changes within the European Union have illustrated the workings of these forces. In the emotive, highly competitive, multi-million dollar pharmaceuticals industry, the effect of the elements of the marketing environment are extensive, particularly for a Japanese player attempting to break into the European 'Single Market'. This article by Sally Dibb, Yvonne Russell and Lyndon Simkin describes the implications in pharmaceuticals of the broader, external trading environment and the marketing environment, using Japan's Sankyo as an illustrative case.",
author = "Sally Dibb and Yvonne Russell and Lyndon Simkin",
year = "1997",
month = "4",
doi = "10.1016/S0263-2373(96)00090-4",
language = "English",
volume = "15",
pages = "195--205",
journal = "European Management Journal",
issn = "0263-2373",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - The EU marketing environment

T2 - Pharmaceuticals and Japanese strategy

AU - Dibb, Sally

AU - Russell, Yvonne

AU - Simkin, Lyndon

PY - 1997/4

Y1 - 1997/4

N2 - The marketing environment those external forces that directly or indirectly influence an organisation's trading, acquisitions of inputs and generation of outputs, but over which the organisation has little or no control - is in marketing strategy acknowledged to be an important determinant of strategy selection. Recent changes within the European Union have illustrated the workings of these forces. In the emotive, highly competitive, multi-million dollar pharmaceuticals industry, the effect of the elements of the marketing environment are extensive, particularly for a Japanese player attempting to break into the European 'Single Market'. This article by Sally Dibb, Yvonne Russell and Lyndon Simkin describes the implications in pharmaceuticals of the broader, external trading environment and the marketing environment, using Japan's Sankyo as an illustrative case.

AB - The marketing environment those external forces that directly or indirectly influence an organisation's trading, acquisitions of inputs and generation of outputs, but over which the organisation has little or no control - is in marketing strategy acknowledged to be an important determinant of strategy selection. Recent changes within the European Union have illustrated the workings of these forces. In the emotive, highly competitive, multi-million dollar pharmaceuticals industry, the effect of the elements of the marketing environment are extensive, particularly for a Japanese player attempting to break into the European 'Single Market'. This article by Sally Dibb, Yvonne Russell and Lyndon Simkin describes the implications in pharmaceuticals of the broader, external trading environment and the marketing environment, using Japan's Sankyo as an illustrative case.

UR - http://www.scopus.com/inward/record.url?scp=0031115842&partnerID=8YFLogxK

U2 - 10.1016/S0263-2373(96)00090-4

DO - 10.1016/S0263-2373(96)00090-4

M3 - Article

VL - 15

SP - 195

EP - 205

JO - European Management Journal

JF - European Management Journal

SN - 0263-2373

IS - 2

ER -